Analysts/Institutional Investor Meet/Con. Call Updates

August 12, 2026 BSE Limited National Stock Exchange of India Ltd. Department of Corporate Affairs Exchange Plaza, Plot No. C/1, G Block P. J. Towers, Dalal Street, Bandra-Kurla Complex, Bandra (E) Mumbai- 400 001 Mumbai- 400 051 Scrip ID-540025 Scrip Code-ADVENZYMES Dear Sir/Madam, Sub: Intimation under Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) - Audio recording of Conference Call for the Unaudited Financial Results for the quarter ended June 30, 2026. This is in furtherance to our letter dated August 04, 2026, intimating about the Conference call for the Analysts and Investors to discuss the Unaudited Financial Results for the quarter ended June 30, 2026. Pursuant to the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), the audio recording of the Conference call held today i.e. on Wednesday, August 12, 2026 on the Unaudited Financial Results for the quarter ended June 30, 2026, is available on the website of the Company at www.advancedenzymes.com/investors/analyst-corner. Further, the transcript of the aforesaid Conference call will be intimated to the Stock Exchanges in due course and uploaded on the website of the Company at the aforesaid link. The aforesaid information is also being uploaded on the website of the Company. Thanking you, Yours Faithfully, For Advanced Enzyme Technologies Limited Sanjay Basantani Company Secretary and Head – Legal